• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠环磷酰胺化疗后,一种特殊标准化槲寄生制剂对中性粒细胞生成的刺激作用。

Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice.

作者信息

Weber K, Mengs U, Schwarz T, Becker H, Lentzen H

机构信息

RCC Research & Consulting Company Ltd., Itingen, Switzerland.

出版信息

Arzneimittelforschung. 1996 Dec;46(12):1174-8.

PMID:9006795
Abstract

Lektinol, is a special mistletoe preparation (SMP) with immunostimulatory activity, standardized with respect to bioactive mistletoe lectin, one of the most active components of mistletoe. In the present study, stimulation of leukopoiesis by SMP was investigated in mice after induction of myelosuppression by the cytostatic agent cyclophosphamide (CP). Under the experimental conditions described, CP induced severe leukopenia followed by a recovery phase where leukopoiesis was distinctly enhanced in mice treated additionally with SMP at daily intravenous doses in a range of 30 to 5000 microliters/kg body weight. This phenomenon was mainly due to a stimulation of granulopoiesis resulting in a stronger increase of metamyelocyte and mature neutrophil counts in the peripheral blood.

摘要

莱克替诺是一种具有免疫刺激活性的特殊槲寄生制剂(SMP),它以槲寄生生物活性凝集素为标准进行制备,槲寄生生物活性凝集素是槲寄生最具活性的成分之一。在本研究中,在通过细胞抑制剂环磷酰胺(CP)诱导小鼠骨髓抑制后,研究了SMP对小鼠白细胞生成的刺激作用。在所描述的实验条件下,CP诱导了严重的白细胞减少,随后进入恢复阶段,在此阶段,以每日静脉注射剂量在30至5000微升/千克体重范围内额外给予SMP治疗的小鼠,其白细胞生成明显增强。这种现象主要是由于粒细胞生成受到刺激,导致外周血中晚幼粒细胞和成熟中性粒细胞数量有更强增加。

相似文献

1
Stimulation of neutropoiesis by a special standardized mistletoe preparation after cyclophosphamide chemotherapy in mice.小鼠环磷酰胺化疗后,一种特殊标准化槲寄生制剂对中性粒细胞生成的刺激作用。
Arzneimittelforschung. 1996 Dec;46(12):1174-8.
2
Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.标准化槲寄生制剂对小鼠肺部转移性B16黑色素瘤定植的影响。
Arzneimittelforschung. 1998 May;48(5):497-502.
3
[Immunoactive action of mistletoe lectin-1 in relation to dose].[槲寄生凝集素-1的免疫活性作用与剂量的关系]
Arzneimittelforschung. 1994 Nov;44(11):1255-8.
4
Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice.半乳糖苷特异性凝集素标准化槲寄生提取物与亚硒酸钠联合给药对BALB/c小鼠的免疫调节作用
Anticancer Res. 1997 May-Jun;17(3C):1893-6.
5
Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.半乳糖苷特异性槲寄生凝集素在经可的松处理的BALB/c小鼠中的免疫保护活性。
In Vivo. 1994 Nov-Dec;8(6):989-92.
6
Mistletoe lectin-1 increases tumor necrosis factor-alpha release in lipopolysaccharide-stimulated whole blood via inhibition of interleukin-10 production.槲寄生凝集素-1通过抑制白细胞介素-10的产生,增加脂多糖刺激的全血中肿瘤坏死因子-α的释放。
J Pharmacol Exp Ther. 2001 Sep;298(3):996-1000.
7
Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.胸腺细胞对半乳糖苷特异性槲寄生凝集素-1的增殖与成熟反应。
In Vivo. 1993 Sep-Oct;7(5):407-10.
8
Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.标准化槲寄生提取物可增强免疫反应,并下调小鼠模型中局部和转移性肿瘤的生长。
Anticancer Res. 2002 Nov-Dec;22(6C):4187-90.
9
Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems.槲寄生中β-半乳糖苷特异性凝集素免疫调节有效剂量的治疗对两种实验模型系统中BALB/c小鼠肿瘤定植的影响。
In Vivo. 1991 Jan-Feb;5(1):29-32.
10
Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay.
Arzneimittelforschung. 1996 Jun;46(6):649-53.

引用本文的文献

1
NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors.NCCAM/NCI 期研究槲寄生提取物和吉西他滨在晚期实体瘤患者中的应用。
Evid Based Complement Alternat Med. 2013;2013:964592. doi: 10.1155/2013/964592. Epub 2013 Oct 27.
2
Oncopharmacological Perspectives of a Plant Lectin (Viscum album Agglutinin-I): Overview of Recent Results from In vitro Experiments and In vivo Animal Models, and Their Possible Relevance for Clinical Applications.一种植物凝集素(欧洲白蜡树凝集素-I)的肿瘤药理学研究进展:体外实验和体内动物模型的近期结果综述及其在临床应用中的潜在意义
Evid Based Complement Alternat Med. 2005 Mar;2(1):59-67. doi: 10.1093/ecam/neh058. Epub 2005 Jan 28.